发明名称 CATIONIC AMPHIPHILES AND PLASMIDS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOLECULES
摘要 Novel cationic amphiphiles are provided that facilitate transport of biologically active (therapeutic) molecules into cells. The amphiphiles contain lipophilic groups derived from steroids, from mono or dialkylamines, or from alkyl or acyl groups; and cationic groups, protonatable at physiological pH, derived from amines, alkylamines or polyalkylamines. There are provided also therapeutic compositions prepared typically by contacting a dispersion of one or more cationic amphiphiles with the therapeutic molecules. Therapeutic molecules that can be delivered into cells according to the practice of the invention include DNA, RNA, and polypeptides. Representative uses of the therapeutic compositions of the invention include providing gene therapy, and delivery of antisense polynucleotides or biologically active polypeptides to cells. With respect to therapeutic compositions for gene therapy, the DNA is provided typically in the form of a plasmid for complexing with the cationic amphiphile. Novel and highly effective plasmid constructs are also disclosed, including those that are particularly effective at providing gene therapy for clinical conditions complicated by inflammation. Additionally, targeting of organs for gene therapy by intravenous administration of therapeutic compositions is described.
申请公布号 EP0799059(B1) 申请公布日期 2002.07.31
申请号 EP19950943769 申请日期 1995.12.08
申请人 GENZYME CORPORATION 发明人 SIEGEL, CRAIG S.;HARRIS, DAVID J.;LEE, EDWARD R.;HUBBARD, SHIRLEY C.;CHENG, SENG H.;EASTMAN, SIMON J.;MARSHALL, JOHN;SCHEULE, RONALD K.;YEW, NELSON S.;LANE, MATHIEU B.;ROWE, ERIC A.;BAGLEY, REBECCA G.;CHANG, CHAU-DUNG
分类号 C12N15/09;A61K9/127;A61K47/28;A61K47/48;A61K48/00;A61P29/00;A61P43/00;C07C211/13;C07C217/28;C07C237/06;C07C271/20;C07C271/34;C07C275/14;C07C279/12;C07C323/25;C07C327/42;C07C333/04;C07J41/00;C07J43/00;C12N15/88 主分类号 C12N15/09
代理机构 代理人
主权项
地址